Relationship between tissue glycation measured by autofluorescence and pulse wave velocity in young and elderly non-diabetic populations

Diabetes and Metabolism

Volumn 38, Issue 5, 2012, Pages 413-419

  Watfa, G ^a,b,c   Soulis, G ^a   Tartagni, E ^d   Kearney Schwartz, A ^a   Borghi, C ^d   Salvi, P ^a,d   Benetos, A ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AGEs; Elderly; Non diabetic; Pulse wave velocity; PVW

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; AGING; ARTERIAL STIFFNESS; ARTICLE; AUTOFLUORESCENCE; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; GLYCATION; HUMAN; MALE; PULSE WAVE; TONOMETRY;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ARTERIES; ELASTICITY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART RATE; HUMANS; MALE; MIDDLE AGED; OPTICAL IMAGING; PULSATILE FLOW; SKIN; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84869104685     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2012.04.004     Document Type: Article

References (32)

1. Maillard L.C. Action des acides aminés sur les sucres: formation des mélanoïdines par voie méthodique. C R Acad Sci 1912, 154:66-68.
2. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
3. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 1990, 45:B105-B111.
4. Nin J.W., Jorsal A., Ferreira I., Schalkwijk C.G., Prins M.H., Parving H.H., et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011, 34:442-447.
5. Asif M., Egan J., Vasan S., Jyothirmayi G.N., Masurekar M.R., Lopez S., et al. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A 2000, 97:2809-2813.
6. Wolffenbuttel B.H., Boulanger C.M., Crijns F.R., Huijberts M.S., Poitevin P., Swennen G.N., et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A 1998, 95:4630-4634.
7. Beisswenger P.J. Glycation and biomarkers of vascular complications of diabetes. Amino Acids 2012, 42:1171-1183.
8. Meerwaldt R., Links T., Zeebregts C., Tio R., Hillebrands J.L., Smit A. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 2008, 7:29.
9. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943.
10. Mattace-Raso F.U., Hofman A., Verwoert G.C., Wittemana J.C., Wilkinson I., Cockcroft J., et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010, 31:2338-2350.
11. Boutouyrie P., Tropeano A.I., Asmar R., Gautier I., Benetos A., Lacolley P., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10-15.
12. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003, 107:2864-2869.
13. Semba R.D., Najjar S.S., Sun K., Lakatta E.G., Ferrucci L. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens 2009, 22:74-79.
14. Ong K.T., Delerme S., Pannier B., Safar M.E., Benetos A., Laurent S., et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens 2011, 29:1034-1042.
15. Cicero A.F., Magni P., Lentini P., Ruscica M., Dozio E., Strollo F., et al. Sex hormones and adipokines in healthy pre-menopausal, post-menopausal and elderly women, and in age-matched men: data from the Brisighella Heart Study. J Endocrinol Invest 2011, 34:e158-e162.
16. Lutgers H.L., Gerrits E.G., Graaff R., Links T.P., Sluiter W.J., Gans R.O., et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009, 52:789-797.
17. Ueno H., Koyama H., Tanaka S., Fukumoto S., Shinohara K., Shoji T., et al. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008, 57:1452-1457.
18. Meerwaldt R., Graaff R., Oomen P.H., Links T.P., Jager J.J., Alderson N.L., et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004, 47:1324-1330.
19. Joly L., Perret-Guillaume C., Kearney-Schwartz A., Salvi P., Mandry D., Marie P.Y., et al. Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese. Hypertension 2009, 54:421-426.
20. Salvi P., Lio G., Labat C., Ricci E., Pannier B., Benetos A. Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens 2004, 22:2285-2293.
21. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl. 1):S11-61.
22. McNulty M., Mahmud A., Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens 2007, 20:242-247.
23. Schram M.T., Schalkwijk C.G., Bootsma A.H., Fuller J.H., Chaturvedi N., Stehouwer C.D. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 2005, 46:232-237.
24. Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E. The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens 2011, doi:10.1038/jhh.2011.59.
25. Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002, 15:1101-1108.
26. Benetos A., Adamopoulos C., Bureau J.M., Temmar M., Labat C., Bean K., et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002, 105:1202-1207.
27. Corman B., Duriez M., Poitevin P., Heudes D., Bruneval P., Tedgui A., et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A 1998, 95:1301-1306.
28. Vlassara H., Fuh H., Makita Z., Krungkrai S., Cerami A., Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A 1992, 89:12043-12047.
29. Yoshida N., Okumura K., Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 2005, 54:345-350.
30. Salvi P., Magnani E., Valbusa F., Agnoletti D., Alecu C., Joly L., et al. Comparative study of methodologies for pulse wave velocity estimation. J Hum Hypertens 2008, 22:669-677.
31. Mulder D.J., Water T.V., Lutgers H.L., Graaff R., Gans R.O., Zijlstra F., et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006, 8:523-535.
32. Peppa M., Uribarri J., Vlassara H. Aging and glycoxidant stress. Hormones (Athens) 2008, 7:123-132.